EUVIMEDEUVIMED entdecken
Crossref

A New Strategy for Controlled In Situ Release of IL‐2 from Tumor Spheroids Using a NIR‐II Light‐Mediated Optogenetic Manipulation System

Hongrui Lin, Junjie Cheng, Rui Li, Chuanwei Zhu, Yan Zhao, Zhiwen Yang, Gang Song, Yiming Huang, Fengting Lv, Haotian Bai, Shu Wang iD

Advanced Materials · 2026

DOI: 10.1002/adma.202516726 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2026. Verfasst von Hongrui Lin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Beijing National Laboratory for Molecular Sciences, Key Laboratory of Organic Solids, Institute of Chemistry, Chinese Academy of Sciences, Beijing, 1…. Hauptthemen laut MEDLINE: Interleukin-2, Spheroids, Cellular, Optogenetics, Infrared Rays. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Beijing Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interleukin‐2 (IL‐2) is a clinically significant immunotherapeutic agent; its short half‐life and poor targeting specificity in vivo have made controlled in situ release an important area of investigation. However, traditional 2D cell experiments and animal studies cannot fully replicate the real environment of human tumors and are limited by interspecies heterogeneity. Here, a NIR‐II light‐mediated optogenetic manipulation system based on photothermal conjugated polymer nanoparticles is successfully constructed, enabling the controlled in situ release of IL‐2 from 3D tumor spheroids. Maintaining tumor spheroids at a relatively low temperature (≈40 °C) can enhance IL‐2 release by up to 4.3 times upon irradiation with 1080 nm laser for 30 min. The released IL‐2 further activates peripheral NK‐92 cells, enhancing the efficacy of immunotherapy. Additionally, the in situ release of IL‐2 specifically upregulates the expression of IL‐2RA on NK‐92 cells, facilitating the formation of high‐affinity complexes between IL‐2 and IL‐2RA. This process activates multiple signaling pathways, including JAK‐STAT, PI3K‐Akt, and MAPK, for improved immunotherapy. Therefore, this NIR‐II light‐mediated optogenetic system provides a promising method for the controlled in situ release of important cytokines in the 3D tumor immune microenvironment for immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-2Spheroids, CellularOptogeneticsInfrared RaysHumansCell Line, TumorNanoparticlesImmunotherapyNeoplasmsKiller Cells, NaturalAnimalsPolymers

Stichwörter der Autor:innen

IL‐2NIR‐II lightimmunotherapyoptogenetic manipulation systemtumor spheroids

Substanzen

Interleukin-2Polymers

Autor:innen und Institutionen

  • Beijing National Laboratory for Molecular Sciences, Key Laboratory of Organic Solids, Institute of Chemistry, Chinese Academy of Sciences, Beijing, 100190, P. R. China.
  • College of Chemistry, University of Chinese Academy of Sciences, Beijing, 100049, P. R. China.

ORCID-Profile: Shu Wang

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Beijing Municipality

Zitieren

APA

Lin, H., Cheng, J., Li, R., Zhu, C., Zhao, Y., Yang, Z., Song, G., Huang, Y., Lv, F., Bai, H., & Wang, S. (2026). A New Strategy for Controlled In Situ Release of IL‐2 from Tumor Spheroids Using a NIR‐II Light‐Mediated Optogenetic Manipulation System. Advanced Materials. https://doi.org/10.1002/adma.202516726

Vancouver

Lin H, Cheng J, Li R, Zhu C, Zhao Y, Yang Z, et al. A New Strategy for Controlled In Situ Release of IL‐2 from Tumor Spheroids Using a NIR‐II Light‐Mediated Optogenetic Manipulation System. Advanced Materials. 2026. doi:10.1002/adma.202516726

BibTeX
@article{Lin2026,
  author = {Lin, Hongrui and Cheng, Junjie and Li, Rui and Zhu, Chuanwei and Zhao, Yan and Yang, Zhiwen and Song, Gang and Huang, Yiming and Lv, Fengting and Bai, Haotian and Wang, Shu},
  title = {A New Strategy for Controlled In Situ Release of IL‐2 from Tumor Spheroids Using a NIR‐II Light‐Mediated Optogenetic Manipulation System},
  journal = {Advanced Materials},
  year = {2026},
  doi = {10.1002/adma.202516726}
}
Kostenlos starten →